Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
948.45
-26.51 (-2.72%)
Official Closing Price
Updated: 7:00 PM EDT, May 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
↗
Today 6:25 EDT
The weight loss drug market is on track to reach almost $100 billion.
Via
The Motley Fool
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
↗
May 08, 2026
GoodRx (GDRX) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Omada Health (OMDA) Q1 2026 Earnings Transcript
↗
May 08, 2026
Omada Health (OMDA) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
↗
May 08, 2026
The competition is far behind.
Via
The Motley Fool
Omada Health Q1 Earnings Call Highlights
↗
May 08, 2026
Omada Health (NASDAQ:OMDA) reported what executives described as a “milestone quarter” for the first quarter of 2026, highlighting 42% year-over-year revenue growth, expanding margins, and positive...
Via
MarketBeat
Topics
Earnings
Eli Lilly's Retatrutide Is So Hot, The Unlaunched Weight-Loss Drug Is Already Getting Knocked Off
↗
May 08, 2026
Eli Lilly's next obesity drug, retatrutide, is so popular it's already getting copied. Can Lilly compete with its own drug?
Via
Investor's Business Daily
How This Eli Lilly-Tied IPO Stock Fared In Its First Quarter
↗
May 07, 2026
IPO stock Omada Health easily beat first-quarter sales expectations Thursday, and announced a deal with drug titan Eli Lilly.
Via
Investor's Business Daily
Topics
Initial Public Offering
Forget Eli Lilly: These 2 Stocks Have More Upside
↗
May 07, 2026
Eli Lilly has a lofty valuation thanks to its strong GLP-1 growth, but don't count out these two competitors.
Via
The Motley Fool
Eli Lilly Now Has the World's Best-Selling Drug -- But Does That Make the Stock a No-Brainer Buy?
↗
May 07, 2026
Mounjaro generated $8.66 billion in sales in the first quarter.
Via
The Motley Fool
What the FDA's Latest Proposal Means for Lilly, Novo, and Hims
↗
May 07, 2026
The FDA's latest proposal would be a win for Eli Lilly and Novo Nordisk, while Hims & Hers Health would also garner indirect benefits.
Via
MarketBeat
My Top Obesity Stock to Buy and Hold
↗
May 07, 2026
Most weight-loss stocks are built on future expectations. Eli Lilly is built on current earnings and expanding demand.
Via
The Motley Fool
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites
↗
May 07, 2026
Eli Lilly plans to invest $4.5 billion in Indiana, expanding its U.S. manufacturing footprint and supporting new weight-loss treatments.
Via
Benzinga
ANI Pharmaceuticals (ANIP) Q1 Earnings: What To Expect
May 06, 2026
Specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) will be reporting earnings this Friday before market open. Here’s what you need to know. A...
Via
StockStory
Topics
Artificial Intelligence
Do Wall Street Analysts Like Eli Lilly Stock?
May 06, 2026
While Eli Lilly has slightly lagged behind the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.
Via
Barchart.com
Topics
ETFs
Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates
May 06, 2026
Animal health company Elanco (NYSE:ELAN) announced better-than-expected revenue in Q1 CY2026, with sales up 14.9% year on year to $1.37 billion. The company ...
Via
StockStory
Topics
Earnings
Collegium Pharmaceutical (COLL) Q1 Earnings Report Preview: What To Look For
May 05, 2026
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be announcing earnings results this Thursday before market open. Here’s what investors sho...
Via
StockStory
Zoetis (ZTS) Q1 Earnings: What To Expect
May 05, 2026
Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Thursday morning. Here’s what you need to know. Zoetis beat analysts’ revenu...
Via
StockStory
Topics
Artificial Intelligence
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
May 05, 2026
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) will be announcing earnings results this Thursday after market hours. Here’s what investors sho...
Via
StockStory
Topics
Artificial Intelligence
Earnings To Watch: Viatris (VTRS) Reports Q1 Results Tomorrow
May 05, 2026
Medication company Viatris (NASDAQ:VTRS) will be announcing earnings results this Thursday before the bell. Here’s what investors should know. Viatris beat a...
Via
StockStory
Topics
Artificial Intelligence
Schrödinger (SDGR) Q1 2026 Earnings Transcript
↗
May 05, 2026
Schrödinger (SDGR) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Eli Lilly Advances As Inflammatory Bowel Disease Drug Reinforces Long-Term Confidence
↗
May 05, 2026
Eli Lilly shares rise as Omvoh shows 4-year disease clearance in ulcerative colitis, with consistent safety and strong Crohn's data.
Via
Benzinga
3 Quality Compounders to Own for Decades
May 05, 2026
Quality compounders are well-oiled machines. Their competitive advantages allow them to make profits consistently and reinvest them into projects that genera...
Via
StockStory
Elanco (ELAN) Q1 Earnings: What To Expect
May 04, 2026
Animal health company Elanco (NYSE:ELAN) will be reporting results this Wednesday before the bell. Here’s what investors should know. Elanco beat analysts’ r...
Via
StockStory
Topics
Artificial Intelligence
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
May 04, 2026
Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings this Wednesday before market hours. Here’s what investors should know. R...
Via
StockStory
Topics
Artificial Intelligence
3 Reasons It's Not Too Late to Buy Eli Lilly Stock
↗
May 04, 2026
The company still has a strong lead in its core therapeutic area.
Via
The Motley Fool
Is Eli Lilly Stock Heading for $1,000?
↗
May 04, 2026
Eli Lilly's valuation looks far more attractive now than it did even a year ago.
Via
The Motley Fool
3 Absurdly Cheap Growth Stocks to Buy in May 2026
↗
May 04, 2026
These stocks have been struggling over the past year, but their growth days are far from over.
Via
The Motley Fool
Here's Exactly Why Wall Street Thinks Viking Therapeutics Stock Could Soar 207% Over the Next 12 Months
↗
May 04, 2026
The Street is bullish on this biotech's prospects, but is the sentiment justified?
Via
The Motley Fool
The Most Surprising Thing About Eli Lilly's Impressive Revenue Growth: Just How Much More Potential There Is
↗
May 04, 2026
Eli Lilly is coming off an impressive first-quarter performance, with sales soaring by 56%.
Via
The Motley Fool
Eli Lilly Topples After Weight-Loss Patient Reports A Surprise Side Effect
↗
May 04, 2026
Eli Lilly stock toppled Monday after a patient taking its new weight-loss pill, Foundayo, experienced liver failure.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
